The European Union Drugs Agency (EUDA), functioning until 30 June 2024 as the European Monitoring Centre for Drugs and Drug Addiction, is the source for drug-related expertise in Europe. The Agency prepares and shares independent, scientifically validated knowledge, alerts and recommendations and works alongside our partners to improve EU preparedness on drugs.

Eurojust and the EUDA share a common commitment to strengthening action against illicit drugs and related crime in the European Union and to the enforcement and implementation of drug trafficking laws.

Since 2007, the Agencies have cooperated closely to this effect through the exchange of strategic and technical information.

Eurojust has contributed to the EMCDDA–Europol EU Drug Markets reports published in 2013, 2016 and 2019. In 2016, the EMCDDA and Eurojust published their first joint publication entitled New psychoactive substances in Europe: Legislation and prosecution – current challenges and solutions.

In July 2014, Eurojust and the EMCDDA signed a Memorandum of Understanding (MoU) to enhance cooperation on drug-related matters and legislation issues relevant to judicial cooperation. Under the provisions of the MoU, the Agencies mutually exchange strategic and technical information (including the collection, analysis and dissemination of relevant data), pool technical expertise, establish joint projects, and ensure the optimal use of resources and information.